Final answer:
According to current guidelines, BiDil is typically added as an adjunct to standard therapy in black patients, but it is not recommended for all black patients.
Step-by-step explanation:
According to current guidelines, BiDil is typically added as an adjunct to standard therapy in black patients.
This means that it is not recommended for all black patients, but rather in specific scenarios where it complements standard therapy.
Option B is the most accurate scenario where BiDil is added only if the patient is unable to take standard therapy.